MATERIALS AND METHODS
Growth curve of S. aureus in the presence of auranofin: MRSA USA300 was incubated with indicated concentration of auranofin for 16 hours at 37°C and the percent bacterial growth was monitored using a spectrophotometer (OD = 600 nm).
Time kill assay:
An overnight culture of MRSA USA300 was diluted to 6 × 10 5 CFU/mL and treated with 5 × MIC of auranofin, vancomycin or linezolid (in triplicate) in Mueller-Hinton broth and incubated at 37°C. Samples were collected at indicated time points, serially diluted in PBS, and transferred to TSA plates. Plates were incubated at 37°C for 24 hours prior to counting MRSA colony forming units (CFU).
DNA intercalation assay: DNA intercalation assay was carried out using pUC 18 plasmid as described elsewhere (1). Briefly, 250 ng of plasmid DNA was incubated with the indicated concentration of auranofin and doxorubicin in a total volume of 25 µl and the reaction mixtures were incubated for 30 min at 37°C. An electrophoretic assay was run using 1% agarose gel without ethidium bromide at 50 volts for 4 hours. The gel was stained with ethidium bromide and visualized for DNA mobility.
Cytotoxicity assay:
In vitro toxicity assay was carried out in murine macrophage (J774A.1) cells utilizing the MTS assay as described before (2) . Briefly, auranofin at a concentration ranging from 0 to 256 µg/ml was added to cells in a 96-well tissue culture plate. After 24 hours of incubation, the cytotoxicity effect of auranofin was measured by the addition of MTS assay were treated with different concentration of auranofin ranging from 0 to 256µg/ml. DMSO was used as a negative control. Cell viability was measured by MTS assay and IC50 of auranofin to cause cytotoxicity in J774A.1 cells was calculated.
